Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Menopause ; 28(6): 699-705, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33534427

ABSTRACT

OBJECTIVE: Systemic arterial hypertension and obesity are major public health problems that increase risks of serious cardiovascular diseases and kidney failure as well as increase mortality. Substances that can alleviate these problems are desirable. We evaluated the beneficial effects of nutritional supplementation with gamma-linolenic acid in postmenopausal hypertensive women. METHODS: This was a prospective, double-blind, placebo-controlled, randomized study involving 96 postmenopausal women. Participants were divided into two groups either receiving 1,000 mg of borage oil rich in gamma-linolenic acid + vitamin E (drug) or only vitamin E (placebo) capsules for 6 months. They were followed up monthly to assess the impact on systemic blood pressure and body composition. To verify group homogeneity, Fisher's exact and Student t tests were performed. To evaluate differences in various parameters between the two groups and at various times, repeated measures analysis of variance was performed, with Bonferroni correction. RESULTS: The power of the test was calculated based on the difference in the mean systolic blood pressure between baseline and after 6 months of treatment in the placebo group and in the drug group. A 92.9% test power was found with a 95% confidence interval. There was a significant reduction in the systolic and diastolic pressure as well as a significant change in waist-hip ratio (P < 0.01) in the drug group as compared with the placebo group. CONCLUSIONS: Supplementation with borage oil rich in gamma-linolenic acid had significant beneficial short-term effects without showing any adverse effect. There remains a need for further studies to evaluate long-term benefits.


Subject(s)
Hypertension , gamma-Linolenic Acid , Adipose Tissue , Dietary Supplements , Double-Blind Method , Female , Humans , Hypertension/drug therapy , Postmenopause , Prospective Studies
2.
Arq Bras Cardiol ; 88(5): 507-13, 2007 May.
Article in English, Portuguese | MEDLINE | ID: mdl-17589623

ABSTRACT

OBJECTIVE: To evaluate the occurrence of variables detecting myocardial ischemia during or after dental treatment under anesthesia with vasoconstrictor (epinephrine). METHODS: A total of 54 coronary patients undergoing dental extraction under local anesthesia with or without vasoconstrictor were included. They were divided into two groups (by drawing envelopes): group I (27 patients) using anesthetics with vasoconstrictor, and group II (27 cases) without vasoconstrictor. 24-hour Holter monitoring, Doppler-echocardiogram before and after dental intervention, and determination of biochemical markers (CK-MB mass, CK-MB activity, and troponin T) before and 24 hours after dental extraction were performed in all patients. Heart rate and blood pressure were also measured in the pre, post-anesthesia and post-dental extraction phases. Doppler echocardiography assessed left ventricular segmental contractility and the occasional occurrence of mitral regurgitation. The usual pharmaceutical treatment prescribed by the cardiologist was maintained in all cases. RESULTS: Three patients in group I presented ST-segment depression (1.0 mm) during administration of anesthesia; two other patients in group I had CK-MB mass elevation, and ischemia was not observed in any other case, as assessed by the other methods. No chest pain, arrhythmias, occurrence or worsening of left ventricular segmental hypocontractility or mitral regurgitation were observed in the study. CONCLUSION: Dental extraction performed under anesthesia with 1:100,000 epinephrine does not imply additional ischemic risks, as long as performed with good anesthetic technique and maintenance of the pharmacological treatment prescribed by the cardiologist.


Subject(s)
Anesthesia, Dental , Dental Care for Chronically Ill/methods , Epinephrine/administration & dosage , Myocardial Ischemia/chemically induced , Tooth Extraction/methods , Vasoconstrictor Agents/administration & dosage , Aged , Anesthesia, Dental/adverse effects , Anesthesia, Local/adverse effects , Biomarkers/blood , Coronary Disease/physiopathology , Creatine Kinase, MB Form/blood , Echocardiography, Doppler , Electrocardiography, Ambulatory , Female , Humans , Male , Middle Aged , Myocardial Ischemia/diagnosis , Tooth Extraction/adverse effects , Troponin T/blood , Vasoconstrictor Agents/adverse effects
3.
Sao Paulo Med J ; 121(1): 34-6, 2003 Jan 02.
Article in English | MEDLINE | ID: mdl-12751343

ABSTRACT

CONTEXT: Leriche syndrome is a thrombotic obliteration of the bifurcation of the aorta, a rare condition that usually affects older men as a result of atherosclerosis. Women of childbearing age rarely need a vascular prosthesis (as a result of Leriche syndrome or other conditions) and there is no literature on an association between Leriche syndrome/vascular prosthesis and pregnancy/labor/delivery. CASE REPORT: A case of pregnancy and delivery in a 38-year-old patient with Leriche syndrome and an aortoiliac prosthesis is presented. The patient had no complications during pregnancy, and was admitted to the maternity hospital when close to term, to begin heparin therapy. Labor ensued spontaneously and a normal vaginal delivery occurred, resulting in a healthy infant. The authors present their considerations regarding the delivery route and the rationale for deciding in favor of vaginal childbirth.


Subject(s)
Delivery, Obstetric , Heart Valve Prosthesis , Labor, Obstetric , Leriche Syndrome/surgery , Pregnancy Complications, Cardiovascular/surgery , Adult , Female , Humans , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...